Cohance Lifesciences Ltd
Cohance Lifesciences's Climate Target Data Preview
As of 2024, Cohance Lifesciences has disclosed 1 climate targets aimed at reducing its greenhouse gas (GHG) emissions. These include 1 absolute reduction target, signaling the company’s commitment to managing and lowering its carbon footprint over time. The targets span various emissions scopes and time horizons, offering insight into Cohance Lifesciences ’s climate strategy, ambition level, and alignment with global decarbonization goals.
| Target Type | Scope of Target | Unit | Target | Target Year |
|---|---|---|---|---|
Absolute-based Target* | Scope 1 - Total, Scope 2 - Total | Metric Tonnes of CO2 equivalent (mtCO2e) | Copy restricted. Please purchase to unlock this data.  a | 2030 |
Create your Tracenable account today and download up to 5 company datasets of your choice for free. No credit card required.
Verified Sources Behind Cohance Lifesciences’s Climate Targets Data
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Cohance Lifesciences’s data sources below and access millions more through our Disclosure Search.
Sign up for Tracenable and access millions of corporate disclosures, including annual reports and sustainability filings from global companies, completely free of charge.
Insights into Cohance Lifesciences's Greenhouse Gas Emissions Pathways
As of 2024, Cohance Lifesciences has set greenhouse gas (GHG) emissions reduction targets that cover its operational emissions (Scope 1 and 2), but not its value chain emissions (Scope 3). This means its reduction efforts currently focus on direct and purchased energy emissions. a
Does Cohance Lifesciences have a target to reduce the emissions from its operations?
As of 2024, Cohance Lifesciences has set a target to reduce its operational greenhouse gas (GHG) emissions, specifically those from Scope 1 and Scope 2 sources. a
Cohance Lifesciences's most ambitious operational target is to reduce these emissions by 35% by 2030, compared to a baseline of 82,316 Metric Tonnes of CO2 equivalent (mtCO2e) in 2023. a
As of 2024, Cohance Lifesciences is ahead of schedule on its operational emissions reduction target, having achieved 57.77% of the planned reduction. a